← Back
3Medicinal

Akkermansia

Also sold as Akkermansia muciniphila, next-generation probiotic

A gut bacterium marketed as a 'natural GLP-1' for weight and blood sugar — based largely on one small human trial.

TrustedSupp Tier System™ · Tier 3Take as a defined course
Check before you startThis one has documented interactions with medication classes where the consequences are serious. If you take any prescription medicine, run it past a pharmacist before starting.

Evidence strength

22/100Weak
WEAKLIMITEDMODERATESTRONGVERY STRONG

What the evidence supports: modest metabolic markers in one small trial of people with metabolic syndrome.

This scores how well-supported the claim above is — not how much benefit you personally would get. A high score on a narrow claim does not extend to everything the product is marketed for.

How long to take it

Course-based while assessing effect.

Who it's actually for

Limited justification yet. The 'natural GLP-1' framing substantially overstates the evidence.

Safe upper limit

Unverified
No formal upper limit
The small human study reported good tolerance. Live bacterial products carry a theoretical infection risk in people who are severely immunocompromised.
No source or citation attached yet.

Interactions to know about

Run your full list through the interaction check.

Practical notes

  • It does not work like GLP-1 medications and is not a substitute for them.
  • The key human trial used a pasteurised form in a small group with metabolic syndrome.
  • Avoid with severe immunosuppression.